Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4 Beta-glucopyranosyloxy-2-hydroxy-3-methoxybenzoyl-2-glucopyranosyloxy Benzyl Ester
2. Leiocarposid
1. 71953-77-0
2. Lejokarpozyd [polish]
3. Brn 5696939
4. [2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 6-hydroxy-2-methoxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate
5. 2'-hydroxybenzyl-3-methoxybenzoate 2',4-diglucoside
6. Leiocarposid
7. Lejokarpozyd
8. Beta-d-glucopyranoside, 2-[[[3-(beta-d-glucopyranosyloxy)-6-hydroxy-2-methoxybenzoyl]oxy]methyl]phenyl
9. Chebi:6403
10. Dtxsid90222239
11. Zinc4098873
12. Mfcd01725338
13. Beta-d-glucopyranoside, 2-(((4-(beta-d-glucopyranosyloxy)-2-hydroxy-3-methoxybenzoyl)oxy)methyl)phenyl-
14. Leiocarposide , Hplc Grade , Hplc Grade
15. Q27107192
16. 2-(beta-d-glucopyranosyloxy)benzyl 3-(beta-d-glucopyranosyloxy)-6-hydroxy-2-methoxybenzoate
17. [2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]methyl 6-hydroxy-2-methoxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-benzoate
18. 2-methoxy-3-(beta-d-glucopyranosyloxy)-6-hydroxybenzoic Acid 2-(beta-d-glucopyranosyloxy)benzyl Ester
| Molecular Weight | 614.5 g/mol |
|---|---|
| Molecular Formula | C27H34O16 |
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 9 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 11 |
| Exact Mass | 614.18468499 g/mol |
| Monoisotopic Mass | 614.18468499 g/mol |
| Topological Polar Surface Area | 255 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 880 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
72
PharmaCompass offers a list of Leiocarposide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Leiocarposide manufacturer or Leiocarposide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Leiocarposide manufacturer or Leiocarposide supplier.
PharmaCompass also assists you with knowing the Leiocarposide API Price utilized in the formulation of products. Leiocarposide API Price is not always fixed or binding as the Leiocarposide Price is obtained through a variety of data sources. The Leiocarposide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Leiocarposide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Leiocarposide, including repackagers and relabelers. The FDA regulates Leiocarposide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Leiocarposide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Leiocarposide supplier is an individual or a company that provides Leiocarposide active pharmaceutical ingredient (API) or Leiocarposide finished formulations upon request. The Leiocarposide suppliers may include Leiocarposide API manufacturers, exporters, distributors and traders.
Leiocarposide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Leiocarposide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Leiocarposide GMP manufacturer or Leiocarposide GMP API supplier for your needs.
A Leiocarposide CoA (Certificate of Analysis) is a formal document that attests to Leiocarposide's compliance with Leiocarposide specifications and serves as a tool for batch-level quality control.
Leiocarposide CoA mostly includes findings from lab analyses of a specific batch. For each Leiocarposide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Leiocarposide may be tested according to a variety of international standards, such as European Pharmacopoeia (Leiocarposide EP), Leiocarposide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Leiocarposide USP).
